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Abstract. The study included 26 patients with FIGO stage Ia1–Ib1 cervical cancer who underwent fertility-sparing 
surgery (transabdominaltrachelectomy). To visualize sentinel lymph nodes, lymphoscintigraphy with injection of 99mTc-
labelled nanocolloid was performed the day before surgery. Intraoperative identification of sentinel lymph nodes using 
hand-held gamma probe was carried out to determine the radioactive counts over the draining lymph node basin. The 
sentinel lymph node detection in cervical cancer patients contributes to the accurate clinical assessment of the pelvic 
lymph node status, precise staging of the disease and tailoring of surgical treatment to individual patient. 
INTRODUCTION 
Cervical cancer is the 7th most common cancer worldwide, accounting for 9.8% of all female cancers. About 
15000 new cervical cancers are estimated to be diagnosed in Russia every year. Cervical cancer is the most common 
among women aged between 40 and 60 with the incidence rate showing an increasing tendency in women diagnosed 
with cervical cancer during their childbearing years. The tendency towards increased incidence is also observed 
among women of the Siberian region of Russia [1, 2]. Because of this trend, there has been an increased emphasis 
on the development of innovative methods and new technologies in the treatment of cervical cancer, as evidenced by 
numerous publications presented in world literature [3, 4]. 
For many malignancies affecting the internal organs and for cervical cancer, in particular, preoperative staging 
assessment is not definitive. At present, the histopathological examination of the surgical specimen is the only 
reliable method, which determines the status of regional lymph nodes and tumor staging. 
Recently, abdominal radical trachelectomy has become more widely used in gynecologic oncology centers for 
treating young women with FIGO stage IA2-IB2 invasive cervical cancer and tumor size of ?6 cm [4–6]. In some 
cases, abdominal radical trachelectomy can be used for stage 1?2-IIA tumors of less than 4 cm in size and having no 
evidence of metastasis [7]. 
Radical abdominal trachelectomy (RAT) is a surgical procedure that removes the cervix, upper one-third of the 
vagina and lymph nodes in the pelvis, while preserving the ovaries, fallopian tubes and the uterine corpus that 
enables subsequent pregnancy and childbirth. Pelvic lymphodenectomy is performed fist and the removed lymph 
nodes are sent for routine pathological examination. If lymph nodes are positive, radical hysterectomy with ovarian 
transposition is performed. If cancer cells are not found in lymph nodes, the cervix with paracervical, parametrial 
tissues and upper one-third of the vagina are removed. A negative proximal resection margin should be 
histologically confirmed [4, 8]. 
The sentinel lymph node (SLN) is the first node to which metastatic disease will spread from a primary tumor. If 
the SLN is free of metastatic disease, all other lymph nodes will also be free of them. Complete pelvic and 
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paraaorticlymphadenectomy may cause severe surgical complications, which can lengthen the duration of hospital 
stay and considerably affect the quality of life of the patients [9–11]. 
Identification of SLNs may help some patients avoid more extensive lymph node surgery, thus minimizing 
postoperative morbidity and significantly improving life quality of the patients [3, 12, 13]. 
The sentinel lymph node detection contributes to the accurate clinical assessment of the lymph node status, 
precise staging of the disease and tailoring of surgical treatment to individual patient [11, 14, 15]. 
The aim of this study was to evaluate the role of SLN detection using preoperative lymphoscintigraphy and 
intraoperative gamma probe and to determine the extent of surgery in organ-preserving treatment for invasive 
cervical cancer. 
MATERIALS AND METHODS 
Between 2010 and 2014, 26 women of reproductive age with stage I cervical cancer underwent radi?al 
transabdominaltrachelectomy. Out of the 26 patients with stage I cervical cancer, there were 7 (27%) with stage Ia1, 
8 (31%) with stage Ia2 and 11 (42%) with stage Ib1. Non-keratinizing squamous cell carcinoma was histologically 
proven in all patients. The mean age of the patients was 28.7 ± 4.5 years. 
All patients were submitted to preoperative lymphoscintigraphy with 99mTc-labelled nanocolloid and 
intraoperative SLN detection using hand-held gamma probe Gamma Finder II (Germany). 
The day before surgery, four injections of 99mTc-labelled nanocolloid at a dose of 20 MBq per quadrant in a 
volume of 0.25 ml per site were made in each quadrant around the cervical tumor. Lymphoscintigraphy consisted in 
obtaining an early image (20 min after injection) and a late image (3 h after injection), in 32 views (low-energy, 
high-resolution, parallel-hole collimator, static image (64?64). The exposure time per projection was 20 s. The data 
obtained were processed using E.Soft (Siemens) software providing three-dimensional images. 
For intraoperative detection of sentinel lymph nodes, the hand-held collimated Gamma Finder II probe was used, 
which allowed the surgeon to precisely locate gamma radiation source and obtain accurate information about the 
distribution of the radionuclide in the tissues and organs of the patient. Intraoperative identification of sentinel 
lymph nodes was performed after opening the retroperitoneal space. The lymph node with radioactivity of at least 
three times more than the background counts was defined as a sentinel lymph node [16]. The sentinel lymph node 
was marked and separately sent for express cytological examination. The lymph node was sectioned transversely 
into 2mm slices. Depending on the size of the node, 6–10 imprints were made from each slice by gently touching the 
cut surface of the node onto a glass slide. Cytological specimens were stained for 15 s using the kit for rapid staining 
of blood smears (Leucodiff 200) and examined with a Zeiss Axio Scope. 
Then the patients underwent iliac-pelvic lymph node dissection. After lymph node dissection, the removed 
lymph nodes were re-examined with gamma probe to detect SLNs missed during intraoperative examination 
(Fig. 1b). The true number of SLNs was calculated as the sum of SLNs identified intraoperatively and in the surgical 
specimen. 
RESULTS AND DISCUSSION 
Single-photon emission computed tomography (SPECT) of the pelvis and abdomen allowed detection of SLNs 
in 21 (80.8%) of patients. A total of 45 nodes were detected by gamma probe during surgery in all 26 patients. Two 
nodes that were missed intraoperatively were subsequently detected in a surgical specimen (Fig. 1). 
Sentinel lymph nodes were found most frequently in the common iliac region (37.7%) and in descending order 
of frequency, in the external and internal iliac regions (28.8% and 17.4%, respectively), in the obturator region 
(9.6%) and in the parametrial region (6.5%). The excised SLNs were intraoperatively evaluated by imprint cytology 
with subsequent routine histological examination of all excised lymph nodes (Table 1). Intraoperative cytology 
revealed metastatic involvement of SLNs only 2 patients. The extent of surgical treatment for these patients was 
increased to radical hysterectomy with ovarian transposition. 
The comparison between the two techniques of SLN detection revealed that the intraoperative gamma probe 
detection technique was more effective than SPECT, showing a sensitivity rate of 93.3% compared to 72%. 
According to a number of studies conducted in leading hospitals around the world, the combined use of the 
radiopharmaceutical tracer and blue dye (isosulfan blue) is the optimal method for SLN detection. Detection by 
99mTc-nanocolloid resulted in a higher yield of SLNs than detection with blue dye with sensitivity rates of 88.5% 
and 83.9%, respectively. The combined technique appears to be the most sensitive diagnostic technique, when the 
likelihood of SLN detection increases to 91.4% [17, 18]. 
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FIGURE 1. (a) Sentinel lymph node visualization (arrow) on SPECT image, (b) gamma probe  
identification of sentinel lymph nodes in the biopsy specimen 
 
A number of studies devoted to the examination of SLN in gynecological cancer are currently conducted [16, 19, 
20]. In 2008, the results of European multi-center study conducted by the National Cancer Institute (Paris) were 
published. They were dedicated to the study of the prognostic significance and anatomical distribution of SLNs in 
cervical cancer. Sentinel lymph nodes were identified using a combination of 99m??-nanocolloid + isosulfan blue 
followed by complete pelvic and praraaortic lymphadenectomy. Sentinel lymph nodes were detected in 96.1% of 
patients, 5.5% of whom were found to have metastases in SLNs, and no positive non-SLNs were present in negative 
SLNs patients. The most common site for SLN detection wasthe external iliac (83.5%). Only 8.5% SLNs were 
located in the common iliac, 5.1% in the presacral and retrosacral areas and 2.7% in the parametrial region [20]. 
Plentl et al. [21] found the SLNs in the parametrial region. SLNs in this location cannot be identified easily by 
gamma probe during surgery because of the proximity of the cervical tumor and the peritumoral area of increased 
radioactivity. The most common site for SLN detection was the obturator fossa (50.4%), followed by the external 
iliac artery (31.4%), the internal iliac artery (15.2%), the common iliac artery (6%), and the cardinal ligament 
(2 nodes). Unilateral SLNs were detected in 52.9%. Possible explanations can be argued that the lymphatic drainage 
of SLN could occur in one side of the pelvis. 
Similar results were obtained by H. Hertel et al. (Sunnybrook Health Sciences Center, ??ronto). SLNs were 
detected in 85% of cases, metastases in SLNs were found in 10% of patients, and no cases with positive non-SLNs 
with the presence of negative SLNs were revealed. The authors reported sensitivity of 92%. To date, in published 
studies, sensitivity ranges from 71% to 100%, diagnostic accuracy from 75% to 100% with specificity of 100% [12]. 
CONCLUSION 
Sentinel lymph node mapping in cervical cancer complements current trends in minimally invasive surgery, 
however, this technique has not yet found wide acceptance in clinical practice as a component of a comprehensive 
examination and treatment of the patients with cervical cancer. Further research is needed to optimize the staging of 
regional dissemination of tumors and, therefore, the choice of adequate treatment [2, 21, 22]. Sentinel node biopsy 
may be a reasonable alternative to avoid extensive pelvic lymph nodes dissection in early stage cervical cancer 
patients with negative SLNs. In contrast, the detection of SLN metastasis during surgery calls for pelvic 
lymphadenectomy to be extended to the para-aortic area. However, larger randomized studies are required before 
recommending routine use of the SLN approach to the determination of the extent of surgical treatment. 
 
TABLE 1. Location of SLNs detected by 99mTc-labelled nanocolloid 
Location of lymph nodes 
On the right side 
n = 6 (13%) 
On the left side 
n = 4 (10%) 
Bilaterally 
n = 35 (77%) 
Common iliac artery 3 2 12 
External iliac artery 1 2 10 
Internal iliac artery 0 0 8 
Obturator fossa 1 0 3 
Parametrial tissue 0 0 3 
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